Fresenius Medical Care AGFMCQF -1.28%74 ROC (Joel Greenblatt) % is 14.51% as of Mar. 2026, which is 37% below its 10-year median of 23.18. GuruFocus rates FMCQF with a GF Scoreâ„¢ of 74/100 and a GF Valueâ„¢ of $47.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 66.22% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Fresenius Medical Care AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.51%.
The historical rank and industry rank for Fresenius Medical Care AG's ROC (Joel Greenblatt) % or its related term are showing as below:
FMCQF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 14.76 Med: 23.18 Max: 60.23
Current: 22.1
During the past 13 years, Fresenius Medical Care AG's highest ROC (Joel Greenblatt) % was 60.23%. The lowest was 14.76%. And the median was 23.18%.
FMCQF's ROC (Joel Greenblatt) % is ranked better than 66.22% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs FMCQF: 22.10
Fresenius Medical Care AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -2.70% per year.
Fresenius Medical Care AG (OTCPK:FMCQF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Fresenius Medical Care AG ROC (Joel Greenblatt) % Related Terms
Fresenius Medical Care AG ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Fresenius Medical Care AG's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG ROC (Joel Greenblatt) % Chart
FMCQF vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's ROC (Joel Greenblatt) % falls into.
Fresenius Medical Care AG ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 14.51% mean?
Fresenius Medical Care AG (FMCQF) has a ROC (Joel Greenblatt) % of 14.51% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Fresenius Medical Care AG and its competitors. This is 37% below median its historical median of 23.18. Over the past decade, Fresenius Medical Care AG's ROC (Joel Greenblatt) % has ranged from 14.76 to 60.23. According to the industry distribution chart, Fresenius Medical Care AG ranks #226 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 33.8%.
Is Fresenius Medical Care AG's ROC (Joel Greenblatt) % too high?
Fresenius Medical Care AG's current ROC (Joel Greenblatt) % of 14.51% is 37% below median its 10-year median of 23.18. Over the past 10 years, this metric has ranged from a low of 14.76 to a high of 60.23. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Fresenius Medical Care AG's value of 14.51% is 16.5% above this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #226 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Scoreâ„¢ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #226 out of 669 companies for ROC (Joel Greenblatt) %. This puts Fresenius Medical Care AG in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.46. Fresenius Medical Care AG's value of 14.51% is 16.5% above this benchmark. Historically, Fresenius Medical Care AG's own ROC (Joel Greenblatt) % has ranged from 14.76 to 60.23 over the past decade. While the company's 10-year median is 23.18 vs. the industry median of 12.46, Fresenius Medical Care AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current ROC (Joel Greenblatt) % of 14.51% is 16.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current ROC (Joel Greenblatt) % is 14.51%, which is 37% below median its own 10-year median of 23.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMCQF) is currently considered Fairly Valued. The stock's GF Value™ is $47.31, compared to a current price of $44.59 — trading 5.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 14.51%, which is 37% below median its 10-year median of 23.18 and 16.5% above the Healthcare Providers & Services industry median of 12.46. Fresenius Medical Care AG's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Fresenius Medical Care AG (FMCQF), the current ROC (Joel Greenblatt) % is 14.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMCQF) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of $44.59 is trading 5.7% below its estimated GF Value™ of $47.31.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMCQF:
ROC (Joel Greenblatt) %: 14.51% (37% below median its 10-year median of 23.18)
GF Value™: $47.31 vs. price of $44.59 (5.7% below fair value)
Industry Position: 16.5% above the Healthcare Providers & Services median (#226 of 669)
No single metric tells the full story. See the FMCQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
74GF Score
Get the complete analysis for FMCQF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMCQF has been successfully added to your 
